Daxor Corporation to Exhibit at the Society for Critical Care Medicine 2023 Critical Care Congress
Oak Ridge, TN, Jan. 13, 2023 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq:DXR), the global leader in blood volume measurement technology, today announces it will be presenting at the Society for Critical Care Medicine (SCCM) 2023 Critical Care Congress at the Moscone Center In San Francisco, CA from January 21 through the 24, 2023.
Related news for (DXR)
- Daxor Corporation Receives FDA Clearance for New Rapid, Lightweight, Blood Volume Analysis System
- 24/7 Market News Snapshot 07 August, 2025 – Daxor Corporation Common Stock (NASDAQ:DXR)
- Daxor Announces Duke University Study on Blood Volume Analysis in Heart Failure Published in American Heart Journal
- Daxor’s Blood Volume Analysis Diagnostic Reaches Two New U.S. Healthcare Systems
- Florida Healthcare Leader Embraces Daxor Blood Volume Analysis Technology